SCHEMBL40572

SCHEMBL40572

CCC(C)(C)c1ccc(OCC(=O)O)c(C(C)(C)CC)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.73
MAPK1 P28482 5/20 0.73
NPSR1 Q6W5P4 5/20 0.73
MEN1 O00255 5/20 0.73
KMT2A Q03164 5/20 0.73
ALDH1A1 P00352 1/20 0.73
PTGDR2 Q9Y5Y4 6/20 0.54
CYP2C19 P33261 1/20 0.54
MAPT P10636 4/20 0.53
HTT P42858 3/20 0.53
UBE2N P61088 2/20 0.53
MITF O75030 1/20 0.53
GLA P06280 2/20 0.50
VDR P11473 1/20 0.46
RAD52 P43351 2/20 0.46
STAT3 P40763 1/20 0.46
RCE1 Q9Y256 1/20 0.46
APAF1 O14727 1/20 0.46
HSP90AA1 P07900 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384191 1.00 SMN1; SMN2 (0.73) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
Hydrochloric Acid SCHEMBL9815917 0.99 SMN1; SMN2 (0.71) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL8161368 0.93 SMN1; SMN2 (0.64) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL7240787 0.90 MAPK1 (0.75) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL11757931 0.88 MAPK1 (0.73) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL1061587 0.87 MAPK1 (0.71) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL4804002 0.87 MAPK1 (0.71) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL76379 0.87 MAPK1 (0.71) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL8087132 0.85 NPSR1 (0.72) SMN1; SMN2MAPK1NPSR1MEN1KMT2A
SCHEMBL13081865 0.85 SMN1; SMN2 (0.68) SMN1; SMN2MAPK1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3982 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035402-A1 C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF ZIKANI THERAPEUTICS INC (US) 2026-02-05 US claimed
EP-3947382-B1 COMPOUNDS FOR USES IN PHARMACOLOGICAL INDUCTION OF HBF FOR TREATMENT OF SICKLE CELL DISEASE AND BETA-THALASSEMIA ACADEMIA SINICA (TW) 2025-09-24 EP claimed
US-12060334-B2 3-substituted phenazine derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-08-13 US claimed
EP-2991655-B1 COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2024-04-10 EP claimed
EP-3606528-B1 TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF BROAD INST INC (US) 2023-10-18 EP claimed
US-11634449-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-25 US claimed
EP-3649135-B1 SYNTHESIS OF HALICHONDRINS HARVARD COLLEGE (US) 2022-12-28 EP claimed
US-20220332747-A1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-10-20 US claimed
EP-3291676-B1 MITRAGYNINE ANALOGS AND USES THEREOF MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2022-08-17 EP claimed
US-11241435-B2 Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis THE GENERAL HOSPITAL CORPORATION (US) 2022-02-08 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
US-6410490-B1 OIL ADDITIVE MIXTURE CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-25 US claimed
EP-1054052-A2 Stabilized hydrotreated and hydrodewaxed lubricant compositions Ciba SC Holding AG (CH) 2000-11-22 EP claimed
US-5808045-A Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides Hiatt, Andrew C. (US) 1998-09-15 US claimed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 WO claimed